Jin Zheng

1.5k total citations
83 papers, 1.1k citations indexed

About

Jin Zheng is a scholar working on Molecular Biology, Surgery and Nephrology. According to data from OpenAlex, Jin Zheng has authored 83 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 27 papers in Surgery and 17 papers in Nephrology. Recurrent topics in Jin Zheng's work include Pancreatic function and diabetes (15 papers), Renal Transplantation Outcomes and Treatments (13 papers) and Acute Kidney Injury Research (9 papers). Jin Zheng is often cited by papers focused on Pancreatic function and diabetes (15 papers), Renal Transplantation Outcomes and Treatments (13 papers) and Acute Kidney Injury Research (9 papers). Jin Zheng collaborates with scholars based in China, Australia and Canada. Jin Zheng's co-authors include Chenguang Ding, Xiaoming Ding, Heli Xiang, Meng Dou, Wujun Xue, Wujun Xue, Puxun Tian, Bo Wang, Xiaofei Yan and Li Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.

In The Last Decade

Jin Zheng

80 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jin Zheng China 19 561 254 185 183 150 83 1.1k
Ting Rao China 20 595 1.1× 267 1.1× 126 0.7× 323 1.8× 132 0.9× 73 1.2k
He-He Hu China 11 554 1.0× 128 0.5× 156 0.8× 273 1.5× 173 1.2× 14 1.3k
Honglian Wang China 21 676 1.2× 203 0.8× 150 0.8× 131 0.7× 223 1.5× 73 1.3k
Zhen Qiu China 14 784 1.4× 195 0.8× 146 0.8× 280 1.5× 109 0.7× 38 1.2k
Peter Nawroth Germany 15 457 0.8× 176 0.7× 155 0.8× 117 0.6× 119 0.8× 32 1.3k
Anna Czajka United Kingdom 17 691 1.2× 223 0.9× 193 1.0× 115 0.6× 68 0.5× 32 1.4k
Matilde Alique Spain 26 846 1.5× 272 1.1× 200 1.1× 113 0.6× 278 1.9× 64 1.8k
Xiubin Liang China 22 855 1.5× 255 1.0× 146 0.8× 170 0.9× 268 1.8× 62 1.5k
Georgios Pissas Greece 23 530 0.9× 154 0.6× 138 0.7× 139 0.8× 281 1.9× 83 1.4k

Countries citing papers authored by Jin Zheng

Since Specialization
Citations

This map shows the geographic impact of Jin Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Zheng more than expected).

Fields of papers citing papers by Jin Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Zheng. The network helps show where Jin Zheng may publish in the future.

Co-authorship network of co-authors of Jin Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Zheng. A scholar is included among the top collaborators of Jin Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Zheng. Jin Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Meihe, Guoxiong Zhou, Ping Lan, et al.. (2025). Characteristics of mismatched eplets affecting de novo donor-specific antibody production and antibody-mediated rejection after kidney transplantation. BMC Nephrology. 26(1). 73–73. 1 indexed citations
2.
Wang, Jingwen, Ying Wang, Bo‐Qing Dong, et al.. (2025). Carboxymethyl chitosan/oxidized carboxymethyl starch Schiff base hydrogels containing fasudil for islet encapsulation and transplantation. Carbohydrate Polymers. 368(Pt 1). 124069–124069.
3.
Xie, Kenan, Jinsong Chen, Longshan Liu, et al.. (2024). Long-term kidney transplant outcomes in Chinese patients with primary glomerulonephritis: A multicenter study in China. Chinese Medical Journal. 137(12). 1492–1494.
4.
5.
Ding, Chenguang, Bo Wang, Greg H. Tesch, et al.. (2023). Cellular delivery of relaxin-2 mRNA as a potential treatment for kidney fibrosis. Materials Today Bio. 21. 100716–100716. 5 indexed citations
6.
Li, Meihe, Shan Gao, Xuan Zhang, et al.. (2023). Quercitrin alleviates lipid metabolism disorder in polycystic ovary syndrome-insulin resistance by upregulating PM20D1 in the PI3K/Akt pathway. Phytomedicine. 117. 154908–154908. 20 indexed citations
7.
Dong, Bo‐Qing, Chenguang Ding, Heli Xiang, et al.. (2022). USP7 accelerates FMR1-mediated ferroptosis by facilitating TBK1 ubiquitination and DNMT1 deubiquitination after renal ischemia–reperfusion injury. Inflammation Research. 71(12). 1519–1533. 30 indexed citations
8.
Wang, Ying, Jiangwei Zhang, Jingwen Wang, et al.. (2022). BMSCs overexpressed ISL1 reduces the apoptosis of islet cells through ANLN carrying exosome, INHBA, and caffeine. Cellular and Molecular Life Sciences. 79(10). 538–538. 7 indexed citations
9.
Wang, Bo, Chenguang Ding, Xiaoming Ding, et al.. (2021). WNT1-inducible signaling pathway protein 1 regulates kidney inflammation through the NF-κB pathway. Clinical Science. 136(1). 29–44. 10 indexed citations
10.
Xiang, Heli, Yang Li, Jin Zheng, et al.. (2020). C1q/TNF‐related protein 6 (CTRP6) attenuates renal ischaemia‐reperfusion injury through the activation of PI3K/Akt signalling pathway. Clinical and Experimental Pharmacology and Physiology. 47(6). 1030–1040. 13 indexed citations
11.
Hu, Xiaojun, Chenguang Ding, Xiaoming Ding, et al.. (2020). Inhibition of myeloid differentiation protein 2 attenuates renal ischemia/reperfusion-induced oxidative stress and inflammation via suppressing TLR4/TRAF6/NF-kB pathway. Life Sciences. 256. 117864–117864. 25 indexed citations
12.
Wang, Xuzhen, et al.. (2019). B-Cell Activating Factor Predicts Acute Rejection Risk in Kidney Transplant Recipients: A 6-Month Follow-Up Study. Frontiers in Immunology. 10. 1046–1046. 17 indexed citations
13.
Ding, Chenguang, Feng Han, Heli Xiang, et al.. (2018). LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma. Journal of Cellular Biochemistry. 119(12). 10406–10414. 32 indexed citations
14.
Yan, Xiaofei, Meng Xun, Litao Wu, et al.. (2018). DRm217 attenuates myocardial ischemia-reperfusion injury via stabilizing plasma membrane Na + -K + -ATPase, inhibiting Na + -K + -ATPase/ROS pathway and activating PI3K/Akt and ERK1/2. Toxicology and Applied Pharmacology. 349. 62–71. 9 indexed citations
15.
Wang, Dan, Xiaoming Ding, Wujun Xue, et al.. (2016). A new scaffold containing small intestinal submucosa and mesenchymal stem cells improves pancreatic islet function and survival in vitro and in vivo. International Journal of Molecular Medicine. 39(1). 167–173. 21 indexed citations
17.
Li, Yang, Wujun Xue, Hongbao Liu, et al.. (2013). Combined Strategy of Endothelial Cells Coating, Sertoli Cells Coculture and Infusion Improves Vascularization and Rejection Protection of Islet Graft. PLoS ONE. 8(2). e56696–e56696. 16 indexed citations
18.
Ding, Xiaoming, Xiaohong Wang, Wujun Xue, et al.. (2012). Blockade of the Nuclear Factor Kappa B Pathway Prolonged Islet Allograft Survival. Artificial Organs. 36(3). E21–7. 8 indexed citations
19.
Zheng, Jin, Xiaoming Ding, Xiaohui Tian, et al.. (2012). Assessment of different biomarkers provides valuable diagnostic standards in the evaluation of the risk of acute rejection. Acta Biochimica et Biophysica Sinica. 44(9). 730–736. 5 indexed citations
20.
Zheng, Jin, Rimas J. Orentas, Xiaofei Yan, & Hongli Liu. (2011). Humoral immune response induced by an engineered cell-based neuroblastoma vaccine with or without CD25 blockade. Acta Biochimica et Biophysica Sinica. 43(2). 124–132. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026